Class 3 Medicines Recall: Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) Accord Healthcare Limited

Class 3 Medicines Recall: Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) Accord Healthcare Limited

July 23, 2020

Class 3 Medicines recall: Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) Accord Healthcare Limited

Drug alert number: EL (20) A/33

Date issued: 23 July 2020

The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for:

Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) Accord Healthcare Limited

Accord Healthcare Limited has informed MHRA they are recalling the above batch as a precautionary measure, due to the observation of precipitation in the solution in the same batch marketed in another country (Malta). No complaints or adverse reaction reports have been received by the company to date for the UK product.

 Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) – PL 20075/0443

 

Batch Number Expiry Date Pack Size First Distributed
X21343 10/2021 1 x 5ml vial 11/03/2019

Advice for healthcare professionals

  • Stop supplying the batch listed above immediately.
  • Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Full drug alert can be viewed here.

For more information or medical information queries, please contact:

Medinfo-BST

Tel: 01271 385257

Email: medinfo@accord-healthcare.com

For stock control queries, please contact:

Accord-UK Ltd Customer Services Team

Tel: 0800 373573

Email: customerservices@accord-healthcare.com

Fax: 01271 346106

 



Posted in:


More Latest News >